Deterministic and Stochastic Model for the Role of the Immune Response Time Delay in Periodic Therapy of the Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|7|4|338-350

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.7, Iss.4, 2011-01, pp. : 338-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers

By  

Current Pharmaceutical Design, Vol. 9, Iss. 12, 2003-05 ,pp. : 945-968

Bentham Science Publishers

Access to resources Recommend Favorite

Combining Cytotoxic and Immune-Mediated Gene Therapy to Treat Brain Tumors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 12, 2005-10 ,pp. : 1151-1170

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Topical Immune Response Modifiers in Skin Cancer

By Woodmansee Courtney   Pillow Jessica   Skinner Robert B.  

Drugs, Vol. 66, Iss. 13, 2006-01 ,pp. : 1657-1664

Adis International

Access to resources Recommend Favorite

A Role for Leptin in the Systemic Inflammatory Response Syndrome (SIRS) and in Immune Response, an Update

By  

Current Medicinal Chemistry, Vol. 13, Iss. 4, 2006-02 ,pp. : 465-475

Bentham Science Publishers

Access to resources Recommend Favorite

Role of miRNAs in the response to anticancer therapy

By Frampton Adam E   Krell Jonathan   Giovannetti Elisa   Jiao Long R   Stebbing Justin  

Pharmacogenomics, Vol. 13, Iss. 15, 2012-11 ,pp. : 1663-1666

Future Medicine

Access to resources Recommend Favorite